NF-κB Inhibitors Impair Lung Epithelial Tight Junctions in the Absence of Inflammation
Overview
Biology
Physiology
Affiliations
NF-κB (p50/p65) is the best characterized transcription factor known to regulate cell responses to inflammation. However, NF-κB is also constitutively expressed. We used inhibitors of the classical NF-κB signaling pathway to determine whether this transcription factor has a role in regulating alveolar epithelial tight junctions. Primary rat type II alveolar epithelial cells were isolated and cultured on Transwell permeable supports coated with collagen for 5 d to generate a model type I cell monolayer. Treatment of alveolar epithelial monolayers overnight with one of 2 different IκB kinase inhibitors (BAY 11-7082 or BMS-345541) resulted in a dose-dependent decrease in TER at concentrations that did not affect cell viability. In response to BMS-345541 treatment there was an increase in total claudin-4 and claudin-5 along with a decrease in claudin-18, as determined by immunoblot. However, there was little effect on the total amount of cell-associated claudin-7, occludin, junctional adhesion molecule A (JAM-A), zonula occludens (ZO)-1 or ZO-2. Moreover, treatment with BMS-345541 resulted in altered tight junction morphology as assessed by immunofluorescence microscopy. Cells treated with BMS-345541 had an increase in claudin-18 containing projections emanating from tight junctions ("spikes") that were less prominent in control cells. There also were several areas of cell-cell contact which lacked ZO-1 and ZO-2 localization as well as rearrangements to the actin cytoskeleton in response to BMS-345541. Consistent with an anti-inflammatory effect, BMS-345541 antagonized the deleterious effects of lipopolysaccharide (LPS) on alveolar epithelial barrier function. However, BMS-345541 also inhibited the ability of GM-CSF to increase alveolar epithelial TER. These data suggest a dual role for NF-κB in regulating alveolar barrier function and that constitutive NF-κB function is required for the integrity of alveolar epithelial tight junctions.
Endothelial TDP-43 depletion disrupts core blood-brain barrier pathways in neurodegeneration.
Omar O, Kimble A, Cheemala A, Tyburski J, Pandey S, Wu Q Nat Neurosci. 2025; .
PMID: 40087396 DOI: 10.1038/s41593-025-01914-5.
Omar O, Kimble A, Cheemala A, Tyburski J, Pandey S, Wu Q bioRxiv. 2024; .
PMID: 38168276 PMC: 10760156. DOI: 10.1101/2023.12.13.571178.
Airway Epithelial Cell Junctions as Targets for Pathogens and Antimicrobial Therapy.
Gao N, Rezaee F Pharmaceutics. 2022; 14(12).
PMID: 36559113 PMC: 9786141. DOI: 10.3390/pharmaceutics14122619.
Non-typeable airways infection: the next treatable trait in asthma?.
Brown M, Jabeen M, Bharj G, Hinks T Eur Respir Rev. 2022; 31(165).
PMID: 36130784 PMC: 9724834. DOI: 10.1183/16000617.0008-2022.
Yuan S, Li Y, Li J, Xue J, Wang Q, Hou X Front Pharmacol. 2022; 13:892790.
PMID: 35873579 PMC: 9301246. DOI: 10.3389/fphar.2022.892790.